We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Microarray Workstation Eliminates Ozone Effects

By Biotechdaily staff writers
Posted on 09 Feb 2006
A new workstation processes microarrays in an ozone-safe environment that eliminates the effects of this air pollutant on array data variability. More...


Scientists from SciGene (Sunnyvale, CA, USA) and Stanford University (Stanford, Ca, USA) presented results at the LabAutomation 2006 conference from studies using SciGene's BriteSpot microarray workstation to examine the effects of ozone on microarray data. This workstation processes arrays in an ozone-safe environment, eliminating the effects of ozone on array data variability.

The BriteSpot system is one of a series of products being developed by the company to improve sensitivity and reliability of microarrays. Components of the workstation include a bench top heating unit for incubating up to 16 arrays in racks ready for processing, a robotic system that processes up to 24 arrays through five temperature-controlled baths into an integral centrifuge for drying, and a NoZone workspace. This is a sealed enclosure with filtration and monitoring equipment that maintains an ozone-safe environment.

Laboratory levels of ozone can degrade fluorescent dyes commonly used in microarray applications. New studies have shown that the effect of ozone is not uniform and leads to spatial distortion of signals across the arrays. This can lead to errors identifying differentially expressed genes when arrays are processed in the presence of nominal levels of ozone within a laboratory.

SciGene is a privately held company founded in 2003, which provides instruments that are used in process control, automation, and protocol optimization to reduce microarray data errors and to enable researchers to obtain reliable results more rapidly.




Related Links:
SciGene

Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
New
Manual Pipetting Aid
Pipette Controllers macro
New
Automatic CLIA Analyzer
Shine i6000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.